Enlightenment Research’s Allergan plc AGN Stock Holding History

Enlightenment Research’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,900	Closed	-$567K	–	304
2019 Q2	$567K	Buy	+3,900	New	+$540K	0.29%	99

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Enlightenment Research's AGN Position: Q3 2019 in Review

Enlightenment Research sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 3,900 shares — an estimated $567K sold.

Enlightenment Research first reported a position in AGN in Q2 2019 and held it in 1 quarter. The position peaked at $567K in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Enlightenment Research reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Enlightenment Research sold 3,900 Allergan plc shares in Q3 2019, an estimated $567K.
Enlightenment Research first reported a position in Allergan plc in Q2 2019 and held it in 1 quarter.
Enlightenment Research's Allergan plc position peaked at $567K in Q2 2019.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Enlightenment Research's 13F filing for Q3 2019, filed 16 Oct 2019.